Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Colorectal Neoplasms

Free Subscription Articles published in Oncology Retrieve available abstracts of 18 articles: HTML format Text format

Single Articles

September 2009
1. CHU E , Shi N, Wei W, Bendell JC, et al
   Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer.
   Oncology. 2009;77.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SOHN BS , Kim TW, Lee JL, Ryu MH, et al
   The Role of KRAS Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients.
   Oncology. 2009;77.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. TSUNODA A , Yasuda N, Nakao K, Narita K, et al
   Phase II Study of S-1 Combined with Irinotecan (CPT-11) in Patients with Advanced Colorectal Cancer.
   Oncology. 2009;77.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
4. SOBRERO A , Ackland S, Clarke S, Perez-Carrion R, et al
   Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer.
   Oncology. 2009;77:113-119.
   PubMed     Text format     Related articles    Abstract available
   
   
   May 2009
5. BEDOYA F , Rubio JC, Morales-Gutierrez C, Abad-Barahona A, et al
   Single Nucleotide Change in the Cannabinoid Receptor-1 (CNR1) Gene in Colorectal Cancer Outcome.
   Oncology. 2009;76:435-441.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2009
6. NIEDER C , Pawinski A, Balteskard L
   Colorectal Cancer Metastatic to the Brain: Time Trends in Presentation and Outcome.
   Oncology. 2009;76:369-374.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. ANGITAPALLI R , Litwin AM, Kumar PR, Nasser E, et al
   Adjuvant FOLFOX Chemotherapy and Splenomegaly in Patients with Stages II-III Colorectal Cancer.
   Oncology. 2009;76:363-368.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. SADAHIRO S , Suzuki T, Maeda Y, Tanaka A, et al
   Phase I/II Study of Twenty-Four-Hour Infusion of Irinotecan in Combination with Oral UFT plus Leucovorin for Metastatic Colorectal Cancer.
   Oncology. 2009;76:338-341.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. BENNOUNA J , Saunders M, Douillard JY
   The Role of UFT in Metastatic Colorectal Cancer.
   Oncology. 2009;76:301-310.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2009
10. KIM MS , Yoo SY, Cho CK, Yoo HJ, et al
    Stereotactic Body Radiation Therapy Using Three Fractions for Isolated Lung Recurrence from Colorectal Cancer.
    Oncology. 2009;76:212-219.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. WANG MJ , Zhou ZG, Wang L, Yu YY, et al
    The Ile646Val (2073A>G) Polymorphism in the Kinase-Binding Domain of A-Kinase Anchoring Protein 10 and the Risk of Colorectal Cancer.
    Oncology. 2009;76:199-204.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
12. ARKENAU HT , Brunetto AT, Barriuso J, Olmos D, et al
    Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer.
    Oncology. 2009;76:151-156.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. POLYZOS A , Tsavaris N, Gogas H, Souglakos J, et al
    Clinical features of hypersensitivity reactions to oxaliplatin: a 10-year experience.
    Oncology. 2009;76:36-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. MARKMAN M
    Therapeutic intent in the conduct of phase I antineoplastic drug trials.
    Oncology. 2009;76:149-50.
    PubMed     Text format     Related articles   
    
    
    
15. MIYAKI M , Yamaguchi T, Iijima T, Takahashi K, et al
    Somatic mutations of the CDC4 (FBXW7) gene in hereditary colorectal tumors.
    Oncology. 2009;76:430-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. YAMANASHI T , Nakanishi Y, Fujii G, Akishima-Fukasawa Y, et al
    Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Oncology. 2009;77:53-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SU X , Lacouture ME, Jia Y, Wu S, et al
    Risk of high-grade skin rash in cancer patients treated with cetuximab--an antibody against epidermal growth factor receptor: systemic review and meta-analysis.
    Oncology. 2009;77:124-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. JATOI A , Green EM, Rowland KM Jr, Sargent DJ, et al
    Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147.
    Oncology. 2009;77:120-3.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: